Skip to Main Content

INFORMATION FOR

David Moore, MD, PhD

Assistant Professor of Psychiatry; Director, VISN 1 Clinical Resource Hub; Chief, Clinical Resource Hub Service Line

Biography

Dr. Moore is a psychiatrist at VA Connecticut and directs the VISN 1 Clinical Resource Hub (CRH).  The VISN 1 CRH provides mental health, primary care, and specialty care services across New England to underserved VA facilities.  His research is in the implementation of complex clinical services treatments via telemedicine and how virtual training programs can support the adoption of evidence-based practices.  He is PI for the VA Office of Rural Health (ORH) National Mental Health and Suicide Prevention ECHO and mPI for the VA ORH National TeleNephrology Hub and Spoke Network.

Education & Training

  • Chief Resident in Quality and Safety
    Yale School of Medicine and VA Connecticut (2017)
  • Resident
    Yale School of Medicine (2016)
  • PhD
    Perelman School of Medicine at the University of Pennsylvania, Biochemistry and Molecular Biophysics (2012)
  • MD
    Perelman School of Medicine at the University of Pennsylvania (2012)
  • MSc
    University of Virginia (2002)
  • BA
    University of Virginia, Echols - Interdisciplinary (2000)

Certifications

  • Board Certification
    American Board of Psychiatry & Neurology, Psychiatry (2016)

Activities

  • Implementing SUD Care in Clinical Resource Hubs
    Virtual Conference 2021
    VHA National SUD Program Conference
  • Telemedicine for Opioid Use Disorder Treatment in the Age of COVID-19
    National Meeting during COVID-19 2021
    American Society of Addiction Medicine
  • Supporting Medications for OUD via Telehealth
    Virtual Symposium 2021
    VHA Stepped Care for Opioid Use Train the Trainer National Meeting
  • Hub and Spoke Telemedicine to Implement and Support MOUD
    Virtual Conference 2020
    American Academy of Addiction Psychiatry
  • Telemedicine Before and After COVID-19
    Virtual Grand Rounds 2020
    Middlesex Hospital Psychiatry Grand Rounds
  • Implementing telemedicine-delivered opioid use disorder treatment: Addressing questions in clinical care
    San Diego, CA, United States 2019
    American Academy of Addiction Psychiatry
  • Using Telehealth to Bring Opioid Use Disorder MAT to Rural Communities
    Bonita Springs, FL, United States 2018
    Annual Meeting of the American Academy of Addiction Psychiatry
  • Mortality in a Supportive Housing Program is Associated with Alcohol Use, Liver Disease, and HIV
    San Diego, CA, United States 2017
    Annual Meeting of the American Academy of Addiction Psychiatry
  • Medical-Surgical Hospitalizations by Veterans with Psychiatric and Substance Use Disorders
    San Diego, CA, United States 2017
    Annual Meeting of the American Academy of Addiction Psychiatry
  • Virtual Doctor Is In: Integrating Telehealth into Addiction Practice Settings
    San Diego, CA, United States 2017
    Annual Meeting of the American Academy of Addiction Psychiatry
  • Characteristics of Veterans Diagnosed with Alcohol Withdrawal and Delirium Tremens
    Bonita Springs, FL, United States 2016
    Annual Meeting of the American Academy of Addiction Psychiatry
  • Mental Illness in the Emergency Department
    Hartford, CT, United States 2016
    NAMI Farmington Valley
  • Mental Illness in the Emergency Department
    New London, CT, United States 2016
    NAMI Southeastern
  • Protein-Protein and Protein-Lipid Interactions Modulate alpha IIb beta 3 Inside-out Signaling.
    New Orleans, LA, United States 2009
    Annual Meeting of the American Society of Hematology
  • Characterization of the Weak Interaction of c-Src with the beta 3 Cytoplasmic Tail
    San Francisco, CA, United States 2008
    Annual Meeting of the American Society of Hematology
  • Interactions between TGF-Beta receptor transmembrane domains.
    Stockholm, Stockholm County, Sweden 2007
    Meeting of the European Protein Society
  • Asymmetric Catalysis by 3-Mono- and 3,3 '-Disubstituted Chiral 1,1'-Bi-2-naphthol Derivatives
    Chicago, IL, United States 2001
    American Chemical Society National meeting